Lab workflows are constantly evolving to handle higher throughput demands, increased efficiency, and more complex tasks. For some, that means allowing automation to play a bigger role in the lab.

Amid an uncertain market with continued pressure to produce positive testing results and a steady downturn in venture capital funding, life sciences startups are being asked to do more with less.

Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of its comprehensive robotics, lab equipment and software platform at the ...

The lab automation market is expected to surpass $8.36 billion globally in 2025 and reach $14.78 billion by 2034. Pharmaceutical and biotech companies are making huge investments in lab automation ...